A Strategic Guide for International Companies
- High-growth market with strong government-led transformation
- Priority opportunities in hospitals, specialized care, and healthtech
- Local partnerships and regulatory readiness
Knowledge Partners:
The Core Investment Thesis
Saudi Arabia is simultaneously the region's largest healthcare market and its most active policy-led transformation story. Government commitment is structural, not cyclical.
- 2024 government healthcare allocation: SAR 214B (~US$57.1B) — this is the annual budget line
- Broader reform infrastructure envelope cited at US$65B+ — a different metric covering facility investment and PPP pipeline
- Total healthcare market projected to reach US$102B by 2035
- Saudi Arabia accounts for ~60% of GCC healthcare expenditure
- Private-sector participation target: 25–35% by 2030 (up from ~20%)
- 95.9% population health coverage already achieved
2024 Budget
2035 Market
GCC Share
Private Target by 2030
Why Saudi Arabia Matters Now
Saudi Arabia is not just a large market — it is a structurally committed one. The government has embedded healthcare transformation into national economic policy through Vision 2030, making it resilient to oil-price cycles.
- Largest healthcare market in MENA; ~60% of GCC healthcare expenditure
- 2024 government healthcare allocation: SAR 214B (~US$57.1B)
- Total market projected at US$102B by 2035 — a 10-year compound growth story
- 95.9% population health coverage already achieved; demand is quality- and capacity-driven, not access-driven
- Privatization target: 25–35% private-sector participation by 2030
- New Investment Law (Feb 2025): registration-based entry replaces prior approval model
- GHE 2025–2026 is the primary relationship-building window for international entrants
2024 Govt Allocation
2035 Market Forecast
GCC Expenditure Share
Population Coverage
Healthcare Transformation
Saudi healthcare has moved from a Ministry-centric model to a distributed, cluster-based delivery system. Understanding the new architecture is essential for any market entry strategy.
Bottom line: Saudi healthcare is moving from policy ambition to operational transformation.
Vision 2030 Launch
HHC Established
Active Health Clusters
New Investment Law
2016
Vision 2030 launched — healthcare privatization and quality targets embedded in national policy
2016–2020
Health Sector Transformation Program (HSTP) — expanded private-sector participation, cluster-based care model introduced
June 2022
Health Holding Company (HHC) established — now the delivery platform running 20–21 regional health clusters
2022–present
NPHIES (National Platform for Health and Insurance Exchange Services) — mandatory for providers and insurers; handles eligibility, pre-authorization, claims exchange
2024
Etimad — the digital procurement platform for government tenders; broader than NUPCO for non-pharma/device categories
February 2025
New Investment Law — registration-based entry model replaces prior approval system
Market Size and Key Metrics
Saudi healthcare figures are frequently misread because multiple metrics circulate simultaneously. Each number refers to a different scope — budget, FX conversion, reform envelope, facility investment, and market projection are not interchangeable.
- SAR 214B: Annual government healthcare budget allocation for 2024 (~US$57.1B at prevailing FX)
- US$65B+: Broader reform infrastructure envelope — includes facility investment pipeline, PPP commitments, and capital programs beyond the annual budget
- US$13.8B: Facility investment target by 2030 — a subset of the reform envelope focused on physical infrastructure
- US$102B: Total healthcare market projection by 2035 — includes public + private + out-of-pocket spend
- 25–35%: Private-sector participation target by 2030 (from ~20% baseline)
- 40–65%: Privatization of 290 hospitals and 2,300 primary health centers — cited in some official sources; verify scope before use
Infrastructure, Privatization & Workforce
Saudi Arabia already has a scaled, functioning healthcare system — not a greenfield market.
- 516 hospitals and 23.4 beds per 10,000 people
- 20–21 HHC health clusters now shape public-sector procurement
- 129,772 physicians, 243,336 nurses, and 46,856 pharmacists
- 175,000 additional healthcare professionals targeted by 2030
- Saudization requirements expanded in 2025 across key clinical roles
516
Hospitals, 2024 baseline
23.4
Beds/10k Population
175K
New roles by 2030
20–21
Health clusters, Public delivery network
Who Does What: The Saudi Healthcare Ecosystem
Buying decisions in Saudi Arabia are increasingly made at cluster, payer, or centrally procured portfolio level — not hospital by hospital. Understanding institutional roles is essential.
MoH
Central government authority
HHC
Care delivery & health clusters
CNHI
Public payer, value-based purchasing
Insurance Authority
Health insurance regulator
SFDA
Pharma & devices regulation
NUPCO
Centralized procurement
CBAHI
Facility accreditation
SCFHS
Practitioner classification
NPHIES
Digital health data exchange
Regulatory & Licensing Pathways
Sequence matters: don't start commercial activity before core registrations are complete.
MISA registration
Full entity setup
SFDA MDMA
SCFHS licensing
Entity Establishment
MISA investment registration: 5–10 working days for the registration step; plan 30–90 days for full entity setup.
Facility Licensing
Unified electronic service; run in parallel with entity setup.
Product Registration
SFDA product registration is mandatory for devices and pharma; MDMA can take 35 business days.
Practitioner Licensing
SCFHS digital practitioner registration in 5 business days.
CBAHI Accreditation
Mandatory pre-launch requirement for all delivery facilities.
Procurement and Buying Behavior
Saudi healthcare procurement is not one market. Four buyer types operate under different rules, timelines, and commercial logic. Misreading the buyer type is the most common commercial error.
Public-sector share of healthcare spend
Buyer types
Public Sector — HHC Clusters + MOH-direct
NUPCO-led centralized buying for pharma and devices. Prequalification is required before any bid. Tender windows can be weeks. Price benchmarked against regional/global references. Etimad is used for broader government procurement.
NPHIES / Insurance Layer
Shapes eligibility, pre-authorization, and reimbursement decisions. Mandatory connectivity for all providers and insurers. Increasingly influences formulary access and device reimbursement.
Private Hospitals & Groups
Structured procurement with clinical evidence, pricing, and service commitments. Major groups: Saudi German, Dr. Sulaiman Al Habib, Mouwasat, Dallah. Faster commercial access than public sector.
Insurers & TPAs
Bupa Arabia, Tawuniya, and Medgulf are the dominant payers. Formulary and reimbursement decisions are increasingly centralized. NPHIES integration is a prerequisite.
Market-Entry Models
The right entry model depends on product type, regulatory pathway, capital availability, and long-term market ambition. Most companies start with a distributor or authorized representative and upgrade the model as the market matures.
Entry models compared
Fastest route, Distributor
PPP/BOT timeline
New Investment Law
Simplifies entity setup
Privatization: What the Numbers Actually Mean
Privatization figures in Saudi healthcare are frequently cited without specifying which metric is being used. Two official framings coexist — and they are not contradictions, they are different scopes.
25–35% private-sector participation by 2030 → Share of total healthcare delivery by private providers (Vision 2030 / NTP targets)
40–65% privatization → Privatization of 290 hospitals and 2,300 primary health centers (Infrastructure transfer program)
Delivery participation target by 2030
Hospitals in privatization pipeline
Primary health centers targeted
Facility investment by 2030
US$13.8B facility investment → Capital investment in new and upgraded facilities (MOH/NTP infrastructure plan)
US$65B+ reform envelope → Total reform infrastructure including PPP pipeline (Broader government commitment)
- The 25–35% target measures delivery participation — how much of total healthcare is provided by private entities
- The 40–65% figure measures asset transfer — how many government-owned facilities are privatized or PPP-converted
- These are complementary metrics, not conflicting ones
- For commercial purposes: the delivery participation target (25–35%) is the more actionable figure for market sizing
- For infrastructure investors: the asset transfer program (290 hospitals, 2,300 PHCs) defines the PPP/BOT opportunity set
NPHIES: The Platform That Reshapes Commercial Access
NPHIES (National Platform for Health and Insurance Exchange Services) is not a background IT system — it is the operational backbone of Saudi healthcare's payer and provider ecosystem. Understanding it is essential for any company selling into the Saudi market.
- Established under MOH; health-insurance responsibilities transferred from CCHI in 2022
- Mandatory for all licensed healthcare providers and insurers operating in Saudi Arabia
- Core functions: eligibility verification, pre-authorization, claims submission, claims adjudication, and health insurance exchange
- Shapes formulary access: insurers use NPHIES data to manage reimbursement lists and pre-auth requirements
- Creates demand for interoperability: HIS, EMR, and billing systems must connect to NPHIES to function in the Saudi market
- For digital health companies: NPHIES connectivity is a procurement prerequisite, not a feature
- For pharma and devices: NPHIES pre-authorization workflows directly affect product uptake in insured private-sector channels
For all providers & insurers
Health insurance responsibilities transferred from CCHI
Key commercial gateway
Primary integration demand
Saudization: Compliance Requirements for Healthcare Companies
Saudization (Nitaqat) requirements for healthcare companies expanded significantly in 2025. Compliance is not optional — it affects licensing, tender eligibility, and operational continuity. Companies must budget for it from day one.
2025
Saudization requirements expanded
SCFHS
Mandatory for all clinical staff
Green/Platinum
Target Nitaqat band
Tender risk
Non-compliance consequence
- Nitaqat program sets mandatory Saudi national employment quotas by company size and sector
- Healthcare sector quotas are among the highest in the economy — clinical roles are prioritized
- 2025 expansion: new Saudization requirements applied to additional clinical and commercial roles including medical representatives, lab technicians, and pharmacy staff
- Non-compliance consequences: restricted MISA licensing, NUPCO tender disqualification, facility licensing delays
- Saudization-ready staffing is now a due diligence criterion for local partner selection
- SCFHS licensing is required for all healthcare professionals — Saudi and expatriate
- Workforce localization is also a commercial differentiator: companies with strong Saudization records receive preferential treatment in public tenders
Entry Timelines and Dependencies
Saudi healthcare entry usually takes longer than expected because each step depends on the one before it.
Low-complexity product route
6–9 months to public-sector engagement
Public-channel revenue
12+ months
Direct entity route
9–15 months to commercial readiness
PPP/BOT route
18–36 months to financial close
Prepare
Dossier, partner selection
Register
SFDA, entity, licensing
Readiness
NUPCO, distributor, KOLs
Activate
Tenders, pilots, sites
SFDA review, business days
Applicant response, calendar days
Entity setup, days
PPP/BOT process, months
Local Partner Strategy
Partner quality directly affects market-entry speed and risk.
- Choose partners through strategic due diligence, not price alone
- Verify NUPCO prequalification, SFDA track record, and compliant warehousing
- Confirm Saudization-ready staffing and financial capacity for the ramp period
- Assess access to target HHC clusters or private hospital groups
Partner Must Show
- NUPCO status
- SFDA compliance
- Licensed cold chain
- Saudization
- Financials
- Target access
Red Flags
- Competing principals
- Single-contact dependence
- No financial transparency
- Unrealistic timelines
Partners amplify commercial execution — they do not replace your regulatory discipline.
Digital Health Opportunities
Saudi Arabia's digital health market is driven by institutional mandate, not consumer adoption. The primary demand signal is regulatory compliance — NPHIES connectivity, MOH mandates, and insurer workflows create non-discretionary adoption drivers.
1. NPHIES Integration
Mandatory for all providers and insurers. Primary entry point for HIS, EMR, and claims integration platforms. Connectivity is a compliance requirement, not a feature.
2. Hospital Information Systems (HIS) & EMR
HHC cluster procurement is the primary buyer. Interoperability with NPHIES and MOH data standards is non-negotiable.
3. Virtual Care & Telemedicine
MOH has expanded virtual care mandates. Cluster-based delivery creates demand for remote monitoring and AI triage tools.
4. Claims Automation & Analytics
Rising payer maturity is driving demand for claims processing, fraud detection, and population health analytics.
5. AI & Decision Support
Diagnostic AI and clinical decision support are early-stage but growing — particularly in radiology and pathology.
6. Data Sovereignty
All health data must be stored in-Kingdom. Cloud and SaaS providers must comply with NCA and MOH data residency requirements.
Mandatory integration standard
Primary institutional buyer
Data residency requirement
Virtual care policy driver
Segment Opportunities: Medical Devices & Pharma
Medical Devices
- NUPCO centralizes demand across consumables, diagnostics, and capital equipment
- Winning categories require more than price: service, localization, and bid discipline matter
- Best opportunities are in complex devices with strong in-Kingdom support requirements
- SFDA MDMA registration can add major delay if dossier preparation is weak
Target for complete MDMA dossiers
Applicant response window per cycle
from weak regulatory preparation
Pharma, Biosciences & Healthcare Services
- Saudi pharma is a US$11.72B market in 2022, with a projected US$15.09B by 2027
- Localization and technology transfer are the top commercial priorities
- Clinical trials are a growing opportunity as SFDA infrastructure and trial sites expand
- Healthcare services remain attractive for PPP and management contracts
- Home care and long-term care are structurally underserved growth areas
Saudi localization is a commercial differentiator, not a CSR exercise.
Commercial Risks and Pitfalls
The most common market-entry failures in Saudi healthcare are not caused by bad products — they are caused by sequencing errors, stakeholder misreads, and compliance gaps that were foreseeable.
1. Regulatory Sequencing Failure
Starting commercial activity before SFDA registration, NUPCO prequalification, or CBAHI accreditation is complete. These are sequential dependencies — not parallel tracks.
2. Outdated Stakeholder Maps
Procurement authority has shifted from MOH to HHC cluster management. Companies still mapping to MOH contacts miss the actual decision-makers.
3. NUPCO Prequalification Gap
Missing prequalification means zero access to public-sector tenders. This is a binary gate — not a competitive disadvantage.
4. Saudization Compliance Risk
Requirements expanded in 2025. Companies must budget for recruitment, training, and compliance overhead across clinical and commercial roles.
5. Single-Tender Concentration
Over-reliance on one NUPCO category or one HHC cluster creates fragile revenue. Diversify across buyer types and clusters.
6. Metric Conflation in Proposals
Citing SAR 214B and US$65B as the same figure in proposals or investor materials is a credibility risk. Always specify scope.
Practical 12-Month Roadmap
Saudi healthcare entry takes longer than most companies expect because each step depends on the one before it. This roadmap is illustrative — actual timelines depend on product complexity, regulatory dossier quality, and partner readiness.
Phase 1 — Q1 (Jun–Aug 2026): Foundation
- Market prioritization and segment selection
- SFDA dossier gap assessment (longest-lead item — start immediately)
- MISA entity setup initiation (5–10 working days registration; 30–90 days full setup)
- Partner longlist and initial due diligence
- HHC cluster mapping and stakeholder identification
Phase 2 — Q2 (Sep–Nov 2026): Registration
- SFDA product registration submission
- SCFHS practitioner registration (if applicable)
- CBAHI accreditation planning (if facility-linked)
- Stakeholder engagement: MOH, HHC cluster management, NUPCO contacts
- Insurer/TPA mapping for private-sector channel
Phase 3 — Q3 (Dec 2026–Feb 2027): Market Readiness
- NUPCO prequalification application
- KOL and key account mapping
- Pilot account selection (private sector for faster access)
- NPHIES integration planning (if digital health or HIS)
- Partner shortlist to 2–3 candidates; begin commercial negotiation
Phase 4 — Q4 (Feb–May 2027): Commercial Activation
- Public-sector tender bids (if NUPCO prequalification complete)
- Private-sector pilot launches
- Reference site development
- 90-day go/no-go expansion review
- GHE 2027 preparation and relationship follow-up
Phases
From setup to scale
Planning horizon
Critical path
Longest-lead item
Go/no-go review
Post-activation check
Final Strategic Checklist
Saudi Arabia rewards evidence-led preparation and disciplined sequencing. This checklist covers the minimum conditions for a credible market-entry commitment.
Before Committing Capital
- Confirm SFDA dossier gaps and realistic registration timeline
- Validate which privatization metric applies to your commercial model (delivery participation vs. asset transfer)
- Check MISA entity setup timing and structure (LLC vs. branch)
- Confirm Saudization requirements for your specific roles and company size
- Verify NUPCO prequalification status and requirements for your product category
- Map target HHC clusters — identify cluster management contacts, not just MOH
- Confirm NPHIES integration requirements if product touches claims, eligibility, or reimbursement
- Assess local partner NUPCO status, SFDA track record, and Saudization compliance
Before GHE / First Market Visit
- Shortlist 3–5 prequalified local partners with verified NUPCO and SFDA credentials
- Prepare realistic regulatory timelines — do not promise what approvals cannot yet deliver
- Map HHC clusters and payer relationships relevant to your segment
- Confirm which buyer type (public, private, insurer) is your primary channel
- Have a localization narrative ready — IKTVA, technology transfer, or Saudization plan
- Know your metric: which figure (SAR 214B, US$65B, US$102B) applies to your pitch and why
After GHE (30/90-Day Actions)
- Assign owners to each relationship within 30 days
- Verify decision-making authority — HHC cluster management, not just MOH contacts
- Track tender dates and NUPCO prequalification windows
- 90-day go/no-go: confirm regulatory pathway, partner selection, and commercial model
Saudi Arabia rewards evidence-led preparation and disciplined sequencing. The companies that succeed are those that treat regulatory compliance as a commercial strategy, not an administrative burden.
Checklist phases
Post-GHE owner assignment
Go/no-go review
SFDA
Longest-lead item, Start first not last
Global Health Exhibition 2025
Show Report
27–30 October 2025
Riyadh Exhibition & Convention Center, Malham, Saudi Arabia
GHE 2025: The Show in Numbers
Attendance
(+83% increase year over year)
Exhibiting Brands
(+83% increase YOY)
Deals Signed
Speakers
(50% International)
Countries
Country Pavilions
Increase in International Attendance
Watching Healthcare Transformation in Action
Global Health Exhibition is the region's definitive platform for impactful partnerships and policy-shaping dialogue. Bringing together global leaders, the show delivered tangible outcomes — from joint ventures and investment deals to cross-border health agreements uniting decision-makers and innovators committed to advancing the future of healthcare.
Show Footprint
Representing a cumulative growth of 233% over two years.
Attendees
2023
Attendees
2024 (+122% YOY)
Attendees
2025 (+50% YOY)
Top 3 Fastest-Growing International Exhibiting Countries (vs 2024)
China
+59.13% YOY
USA
+76.45% YOY
Turkey
+339% YOY
Top Show Sectors
Government
Hospitals & Healthcare General Services
Medical Devices
A Global Healthcare Magnet
2,200 exhibiting brands
85% of which are international brands
Top Participating Countries
Germany
USA
Austria
China
Canada
UK
Italy
Belgium
Turkey
South Korea
Egypt
Pakistan
Taiwan
India
Spain
Australia
Sweden
Portugal
Finland
South Africa
"The Global Health Exhibition is a critical platform for us because Saudi Arabia's healthcare ecosystem is advancing faster than ever before. Our presence here allowed us to connect with key stakeholders, policy makers, clinicians, and customers, understand emerging needs and showcase how diagnostic innovation can help accelerate the Kingdom's ambitions."
— Muhieddine Makkouk, Vice President & General Manager, Danaher Diagnostics Platform, Saudi Arabia
Showcasing Saudi Arabia's Fastest-Growing Investment Hub
$35.5B in strategic deals announced across the show in the areas of: Life Sciences & Med Tech | Hospital & Healthcare Infrastructure | Venture Capital & Strategic Funds
Committed to hospital and healthcare infrastructure development across Saudi Arabia
Allocated to venture capital and strategic investment funds
Channelled into the life sciences sector
Among the most notable signed agreements and MOUs
Strategic Investor Collaboration
The Global Health Exhibition's Investor Forum connected leading capital with transformative healthcare opportunities in Saudi Arabia.
Assets Under Management
Investors
Countries
Scheduled Investor Meetings
Investment Forum Attendees
Top Participating Countries
USA
UK
Germany
China
UAE
Top Investment Institutions Participating
TVM Capital
Deerfield
Blackstone
AMGEN
Biospring
Science Capital
Heal Capital
Santé
Plug and Play
Quadria Capital
Attracting the Right Audience
131,000 Attendance Across The Four Days
Government
Dealers and Distributors
Healthcare Professionals
Hospital & Clinic Management
Lab Professionals
Investors
24% decision makers
10% C-levels and executives
"The Global Health Exhibition was more than just an event; it was a powerful glimpse into the future of healthcare. The exhibition successfully showcased cutting-edge innovations and pivotal strategies set to redefine patient care and public health globally."
— Aashima Gupta, Global Director, Healthcare, Google Cloud
Top Attending Countries
YOY growth in primary & secondary countries
Countries
Increase in International Attendance
Increase in Primary Countries Attendance
Increase in Secondary Countries Attendance
Top Attending Countries
United States
China
UK
Egypt
Saudi Arabia
India
Germany
UAE
Türkiye
Jordan
"The Global Health Exhibition provides an excellent opportunity to share innovative approaches and collaborate on solutions that will have a real impact on the urgent health challenges facing communities worldwide."
— Sir Jonathan Symonds CBE, GSK
Delivering Measurable ROI & Commercial Success
Overall event score
(up from 39 in 2024)
Net promoter score
compared to 2024
Scanned Leads
at the event
Expected business sales
on average in the next 12 months
Rebooking rate
Satisfaction Data
Why Global Health Exhibition Matters
In Their Words
Innovation at the Forefront
Cutting-edge healthcare technologies, AI solutions, and global advancements.
Powerful Networking Hub
Direct access to key stakeholders, partnerships, and business opportunities all in one place.
World-Class Learning Platform
High-value education through scientific sessions, workshops, and CME programs.
Net promoter score
(up from 50 in 2024)
Are likely to come back next year
Said event is important to them
4 Stages. CME-Accredited Insights. Niche Workshops
Speakers
Attendance
Sessions
CME Hours
Hours of Content
Tracks
Leaders Summits
Medical Excellence Forum
Investor X Venture Forum
Digital Health Forum
CME Accredited Workshops and Masterclasses
Healthcare's Brightest Minds Took Centre Stage
Health Care Leaders
HRH Prince Khaled bin Alwaleed bin Talal Al Saud — President, Saudi Sports for All Federation (SFA), Founder & CEO, KBW Ventures
H.E Prof. Dr Khaled Abdel-Ghaffar — Deputy Prime Minister for Human Development and Minister of Health & Population, Arab Republic of Egypt
HE Hosams Abu Meri — Minister for Health, Ministry of Health of the Republic of Latvia
Baroness Nicola Blackwood — Member of the House of Lords, Chair of Genomics England, Former Minister of Health
Global CEOs
Sir Jonathan Symonds — Chair, GSK
Toshio Takiguchi — Chief Executive Officer, Canon Medical
Joseph Romanelli — President Human Health International for Merck (MSD)
Frederic Oudea — Chairman of the Board of Directors, Sanofi
Speaker origin breakdown
International
Saudi Arabia
GCC
NextGen Pitch Competition
The NextGen Pitch Competition is the global stage for healthcare startups & scaleups. Aligned with Vision 2030, finalists pitch in dedicated tracks in AI, MedTech & Biotech innovation.
Entries Received
Unique Countries Applied
Semi-Finalists Chosen by Judging Committee
Grand Prize
Winner: exōheal
Judges Include:
Omar Khalil, Managing Director, Sante Ventures
Jennifer Lum, Managing Partner, Biospring Partners
Ayah Hamdan, Director, Ventures & Head of Health, Plug and Play
Community Partners: Startupbootcamp | Plug and Play
Sponsored by: Persivia
Competition Finalists Include:
XYLeap
iXA
DRYLABZ
Outcomes4Me
ovasave
INITIO CELL
exōheal
Abi
SYLKE
Live Well Youth Competition
Supported by the Ministry of Health's LiveWell initiative, the Live Well Youth Competition empowers young talents to create cutting-edge wellness technology. Teams of 1–6 pitch transformative solutions in digital health & wellness.
Universities
Submissions
Participants
Prize money
Winner: VITRAC
VITRAC — "A lifelong, multilingual health companion that connects daily habits such as sports, exercise, and travel with clinical follow-ups. Winners from King Abdulaziz University, Faculty of Medicine."
Supporting Universities
Princess Nourah bint Abdulrahman University
King Khalid University
Alfaisal University
King Faisal University
King Saud University
KSAU
Sponsored by: Roche
Health Datathon
Data scientists, AI innovators, and health enthusiasts pitched real-world solutions that transformed health through data in the areas of reducing premature mortality and extending healthy lifespan through genomics and biotechnologies.
Participants
Winners
Prize Money
Sponsored by: HEVOLUTION, VIA (MOZN.AI), @LiveWellMOH, CODE (Center of Digital Entrepreneurship), Saudi Authority for Intellectual Property, nupco, SDAIA
In partnership with: Misk Foundation, Ministry of Health, DAL
Experiences That Enhanced Engagement
Wellness Technology Spotlight emerged as the most enjoyed feature at the show, attracting 37% of visitors, standing out as the top experiential highlight.
Top features rated by visitors
Wellness Technology Spotlight
Health Memory Museum
Live Well Youth Competition
Immersive Active Arena
Medical Escape Room
Social Club Experience
Fit & Flow Basketball
Experience Highlights
Wellness Technology Spotlight
Immersive Active Arena
Fit & Flow Basketball
Medical Escape Room 2.0
Health Memory Museum
Art & Health
Launching VIBE
Saudi Arabia's Newest Platform for Holistic Health, Longevity & Wellness Innovation
VIBE attracted prominent wellness and fitness exhibitors, including Technogym, Samsung, Fine Solutions, Biofit, Delta Fitness, Ultrahuman, Optimo, B_Fit and others, underscoring the event's growing relevance within the wellness ecosystem.
VIBE featured immersive experiences that linked wellness with technology and play.
Attendees engaged with the VIBE Social Club, which included a basketball shooting zone and interactive fitness activations designed to connect physical movement with mental wellbeing.
Another key highlight was the LiveWell Youth Competition, sponsored by Roche. Supported by seven Saudi universities, the competition attracted 117 team submissions and over 600 participants, demonstrating the creativity and innovation of the next generation in shaping the future of wellness.
Expanding And Amplifying Our Digital Reach
1.15 Billion cumulative impressions across all platforms
PR Impressions
Social media impressions
Digital impressions (Across Google and programmatic marketing)
active users on the website
Outdoor advertising reach
Email campaigns impressions
PR Exposure Across The Globe
Regional breakdown
Audience reach
Article views
Press releases (vs. 8 in 2024)
Articles
Earned media
Saudi Arabia: 54.6M
North America: 1,521,884
Latin America: 1,515,000
Europe: 67,653
Middle East & Africa: 77,077
Asia-Pacific: 7,993
Featured in:
Sky News
Financial Times
Forbes
Bloomberg
Gulf Business
CNBC
Al Arabiya
Arab News
City A.M.
Inside Saudi
Fast Company
Event App: Download & Engagement
Total app downloads (+106% YOY)
Active users
Engagement rate
Total contacts made
Agenda page views
Exhibitor page views
Event map views
Why Exhibit at GHE 2026
Join leading global brands seizing the healthcare opportunity in Saudi Arabia
Access a rapidly expanding market
Meet the right audience
Be in the place where business gets done
Key healthcare sectors that drove partnerships, investment, and innovation at GHE 2025
Production of ultrasound imaging devices
Bringing world-class sports medicine to the Kingdom
Support pharmaceutical manufacturing and R&D
Establish new specialty healthcare centers
Build clinical research capabilities
Manufacture blood bags locally
Advanced hospitals and primary health clinics
Saudi Arabia is Set to Become a Top 20 Global Healthcare Market
It combines scale, government-backed transformation, investment momentum, and fast innovation adoption, creating the region's most dynamic and commercially attractive healthcare ecosystem.
US$135 bn
The expected value of the Saudi healthcare sector by 2027. CAGR of 6.4% from 2024–2032
US$116.7 bn
Expected total Healthcare expenditure by 2029
7.2%
Annual growth rate (Sources: MOH.GOV.SA, BMI Report)
Better Stands Program
Better quality. Better safety. Better time efficiency. Better sustainability.
A Better exhibition experience. Informa Better Stands, working together to move away from disposable stands.
Did you know? Over 95% of The Space-Only exhibition stands are disposable.
Tahaluf is supporting the Better Stands Program, demonstrating a commitment to reducing disposable stands at our events. The goal is to empower all space-only exhibitors to achieve a Bronze stand rating this year.
Choose Modular, Reconfigurable Designs
Reuse stand platform ★ Qualifies for Bronze rating
Reuse stand structure & walls ★ Qualifies for Bronze rating
Reuse furniture and digital displays ★ Qualifies for Bronze rating
Install Energy-Efficient Lighting & Equipment
Use High-Quality, Durable Materials
Contact: sales@globalhealthsaudi.com
GHE 2026 at a Glance
Dates: 26–29 October 2026
Venue: Riyadh Exhibition & Convention Center, Malham, Saudi Arabia
The Global Health Exhibition brings together the full spectrum of healthcare innovation, driving collaboration and investment in Saudi Arabia's evolving health landscape and beyond. Returning on 26–29 October 2026, it will feature VIBE, a co-located event powered by the Ministry of Health's Live Well initiative, dedicated to holistic health, longevity, and wellness innovation under Vision 2030.
Key Sectors
Government
Healthcare & General Services
Digital Health
Medical Devices
Imaging & Radiology
Life Sciences
Start-ups
Wellness
Disposables
Thank You To All Our 2025 Sponsors and Partners
National Health Partner
Health Holding Co
Foundation Partners
NUPCO, Saudi Commission for Health Specialties, Dallah Health, Hayat National Hospitals
Health Innovation Partner
Lean
Digital Enabler
STC
Diamond Partners
Tawuniya, WuXi AppTec
Platinum Partners
Bupa CareConnect, Al Rajhi Takaful
Gold Partners
Ejada, VERTEX
Silver Partners
DaVita, Johnson & Johnson, AstraZeneca, MSD
Sustainability Partner
Riyadh Region Municipality
Air Mobility Strategic Partner (UAM)
THC
Get in Touch
Interested? Join us at GHE 2026
Dates: 26–29 October 2026
Venue: Riyadh Exhibition & Convention Center, Malham, Saudi Arabia
Head Of Sales
Sales, Sponsorship & Partnerships
Speaking Opportunities
Marketing & Media Opportunities
Under the Patronage of: Ministry of Health
Supported by: Vision 2030, Health Sector Transformation Program
Organized by: Tahaluf (an Informa company)
Roadmap to Entering the KSA Healthcare Market